Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christine Desmedt Vinu Jose Sherene Loi Sibylle Loibl Mark J. Smyth Carsten Denkert Stefan Michiels Pirkko-Liisa Kellokumpu-Lehtinen Heikki Joensuu Vesa Kataja |
| Publication date | March 7, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |